Purple Biotech Ltd (KTOV) — Financial Flexibility Index

Latest as of June 2020: -0.08x

Purple Biotech Ltd (KTOV) has a Financial Flexibility Index of -0.08x as of June 2020. Free cash flow of ILA-2.32 Million (operating CF ILA-2.32 Million minus capex ILA0.00) represents 0% of total liabilities (ILA29.64 Million). Also explore how fast is Purple Biotech Ltd growing its equity to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.08x
Free Cash Flow / Total Liabilities

Free Cash Flow

ILA-2.32 Million
Operating CF − Capex

Total Liabilities

ILA29.64 Million
ILA

Capital Expenditures

ILA0.00
ILA

Purple Biotech Ltd Financial Flexibility Index (2013–2019)

Historical Financial Flexibility Index trend for Purple Biotech Ltd across 7 annual periods. Check KTOV capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Annual Financial Flexibility Index for Purple Biotech Ltd (2013–2019)

Year-by-year free cash flow to debt coverage for Purple Biotech Ltd. For the full company profile including market capitalisation, see KTOV company net worth.

Year Flexibility Index Free Cash Flow (ILA) Operating CF Total Liabilities YoY Change
2019 -1.44x ILA-5.57 Million ILA-5.58 Million ILA3.86 Million ▲ +36.6%
2018 -2.28x ILA-8.46 Million ILA-8.48 Million ILA3.72 Million ▼ -47.7%
2017 -1.54x ILA-8.61 Million ILA-8.63 Million ILA5.59 Million ▲ +62.3%
2016 -4.09x ILA-6.25 Million ILA-6.26 Million ILA1.53 Million ▼ -71.4%
2015 -2.39x ILA-3.30 Million ILA-3.31 Million ILA1.38 Million ▲ +52.0%
2014 -4.97x ILA-4.52 Million ILA-4.53 Million ILA908.00K ▼ -1143.2%
2013 -0.40x ILA-503.00K ILA-512.00K ILA1.26 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities